Seeking to change lives with next generation peptide therapeutics

Registration for Zealand Pharma’s Obesity R&D Event on December 5, 2023 is now open

Zealand Pharma at Jefferies London Healthcare Conference

November 14, 2023 at 1:30 p.m. GMT (2:30 p.m. CET)

Read more


Q3/9M 2023 Financial Results

November 9, 2023

2:00pm CET (8:00am ET)

Read More


Phase 3 clinical trials to investigate survodutide for people living with obesity and overweight…

Our research

Applying our peptide platform to specialty disease areas to invent novel therapies.
Read more

Clinical pipeline

Advancing development programs in rare diseases and obesity. See our pipeline

About Zealand

Get a brief overview on Zealand and learn more about our company. Read more


Information for analysts, investors, and shareholders.
Read more